-
Mashup Score: 3Environmental, Social & Governance - 4 day(s) ago
We are advancing environmental, social and governance (ESG) initiatives that contribute to the sustainable growth of our company so that we can create positive impact for generations to come. Our ESG framework is built around three pillars that were developed based on our six core material drivers: product innovation, human capital management, product quality and safety, business ethics, patient health and engagement, and patient access and affordability.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7
See how the AbbVie-Calico Life Sciences collaboration turns the traditional partnership upside down to tackle age-related diseases.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 13Neuroscience - 23 day(s) ago
AbbVie scientists are focused on how to bring better solutions and therapies to people living with neurological and psychiatric disorders.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 14The Case for Big Bets - 1 month(s) ago
Because thinking small never changed the world.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 12A Legacy Of Leadership In Mental Health - 1 month(s) ago
Leveraging years of research and development, AbbVIe scientists are committed to finding answers to some of the most complex questions in psychiatry.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 3Not good enough: behind the drive to give cancer patients more time - 2 month(s) ago
Two R&D leaders discuss AbbVie’s approach to develop solid tumor treatments.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Immunology’s Next Frontier - 2 month(s) ago
Twenty years ago, Tim Radstake, M.D., saw history in the making – the results of a new treatment for patients with rheumatoid arthritis (RA), a chronic, autoimmune disease. At the hospital where he worked at the time, the treatment was administered to one of its very first patients. Later, the patient’s husband came back, filled with emotion. “When we saw him, everyone feared something was wrong, but what actually happened was his wife was able to do something she hadn’t done in years – get out of
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7Immunology - 2 month(s) ago
AbbVie develops innovative medicines and therapies so patients can live more fully. Learn more about our immunology research to address chronic diseases.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 9Neuroscience - 3 month(s) ago
AbbVie scientists are focused on how to bring better solutions and therapies to people living with neurological and psychiatric disorders.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet-
#ParkinsonsDisease (PD) is a progressive and chronic movement disorder characterized by tremor, muscle rigidity, slowness of movement and difficulty with balance. We’re relentless in moving #science forward to make a difference for this community. More: https://t.co/1uvqFWCtj2 https://t.co/N8pQvtowmC
-
-
Mashup Score: 6Not good enough: behind the drive to give cancer patients more time - 4 month(s) ago
Two R&D leaders discuss AbbVie’s approach to develop solid tumor treatments.
Source: www.abbvie.comCategories: General Medicine News, PayerTweet
Honored to be recognized as a 2024 @ENERGYSTAR Partner of the Year for Sustained Excellence in Energy Management. Read more about our #sustainability efforts: https://t.co/gvOGPR2rGl #ENERGYSTARawards https://t.co/7BIFIv60hT